9G4-targeted bispecific T cell engagers and CAR-T cells

Written by Maximilian Konig

We developed IGHV4-34-targeted chimeric TCR-T cells, CAR-T cells, and bispecific T cell engagers, precision immunotherapies for the selective elimination of 9G4 idiotope B cells in lupus, cold agglutinin disease, and lymphoma.

Maximilian Konig
Previous

Bispecific autoantigen-T cell engagers (BaiTE)
Next

TRBV9-targeted bispecific T cell engagers